mTOR Signaling in Growth, Metabolism, and Disease - PubMed (original) (raw)
Review
mTOR Signaling in Growth, Metabolism, and Disease
Robert A Saxton et al. Cell. 2017.
Erratum in
- mTOR Signaling in Growth, Metabolism, and Disease.
Saxton RA, Sabatini DM. Saxton RA, et al. Cell. 2017 Apr 6;169(2):361-371. doi: 10.1016/j.cell.2017.03.035. Cell. 2017. PMID: 28388417 No abstract available.
Abstract
The mechanistic target of rapamycin (mTOR) coordinates eukaryotic cell growth and metabolism with environmental inputs, including nutrients and growth factors. Extensive research over the past two decades has established a central role for mTOR in regulating many fundamental cell processes, from protein synthesis to autophagy, and deregulated mTOR signaling is implicated in the progression of cancer and diabetes, as well as the aging process. Here, we review recent advances in our understanding of mTOR function, regulation, and importance in mammalian physiology. We also highlight how the mTOR signaling network contributes to human disease and discuss the current and future prospects for therapeutically targeting mTOR in the clinic.
Keywords: aging; cancer; cell growth; diabetes; mTOR; mTORC1; mTORC2; metabolism; nutrients; signaling.
Copyright © 2017 Elsevier Inc. All rights reserved.
Figures
Figure 1. mTORC1 and mTORC2
(A) The mTORC1 and mTORC2 signaling pathways. (B) mTORC1 subunits and respective binding sites on mTOR. The FKBP12-rapamycin. The 5.9 Å cryo-EM structure of mTORC1 (without DEPTOR and PRAS40, PDB ID: 5FLC) from is depicted as a space filling model and colored by subunit. (C) mTORC2 subunits and respective binding sites on mTOR.
Figure 2. The mTOR Signaling Network
(A) The signaling pathways upstream of mTORC1 and mTORC2. Positive regulators of mTORC1 signaling are shown in yellow, while negative regulators are shown in blue. mTORC1 and mTORC2 are shown in green and red, respectively. (B) The major signaling pathways downstream of mTORC1 signaling in mRNA translation, metabolism, and protein turnover. (C) mTORC1 controls the activity of several transcription factors that can also be independently regulated by cell stress. (D) The major signaling pathways downstream of mTORC2 signaling.
Figure 3. Evolutionary Conservation of the mTOR Pathway
(A) The nutrient sensing pathway upstream of mammalian mTORC1 (left) and yeast TORC1 (right). (B) Phylogenetic tree depicting the presence (green box) of key mTORC1 regulators in various model organisms.
Figure 4. Physiological Roles of mTOR
(A) mTORC1 controls the balance between anabolism and catabolism in response to fasting and feeding. (B) The effect of cumulative mTORC1 activity on overall health. (C) The effect of mTORC1 hyperactivation in pancreatic β-cells on glucose tolerance over time. (D) The normal functions of mTORC1 in the liver, muscle, pancreas, and adipose tissue (left), and the consequences of chronic mTORC1 inhibition (middle) or activation (right). (E) Deregulation of mTORC1 signaling in insulin resistance/diabetes, and the effect of rapamycin or a theoretical mTORC1 specific inhibitor.
Figure 5. mTOR in Cancer and Aging
(A) The common tumor suppressors and oncogenes upstream of mTORC1 leading to increased mTORC1 signaling in a wide variety of cancers. (B) The varying effects of rapalogs, catalytic mTOR inhibitors, a combination of an mTOR inhibitor and autophagy inhibitor on cancer proliferation and survival. (C) The role of mTORC1 signaling in aging.
Similar articles
- Polyploidy and mTOR signaling: a possible molecular link.
Choudhury D, Ghosh D, Mondal M, Singha D, Pothuraju R, Malakar P. Choudhury D, et al. Cell Commun Signal. 2024 Mar 27;22(1):196. doi: 10.1186/s12964-024-01526-9. Cell Commun Signal. 2024. PMID: 38539200 Free PMC article. Review. - mTOR signaling in stem and progenitor cells.
Meng D, Frank AR, Jewell JL. Meng D, et al. Development. 2018 Jan 8;145(1):dev152595. doi: 10.1242/dev.152595. Development. 2018. PMID: 29311260 Free PMC article. Review. - Deconvolution of mTORC2 "in Silico".
Fingar DC, Inoki K. Fingar DC, et al. Sci Signal. 2012 Mar 27;5(217):pe12. doi: 10.1126/scisignal.2003026. Sci Signal. 2012. PMID: 22457328 - mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.
Perluigi M, Di Domenico F, Butterfield DA. Perluigi M, et al. Neurobiol Dis. 2015 Dec;84:39-49. doi: 10.1016/j.nbd.2015.03.014. Epub 2015 Mar 19. Neurobiol Dis. 2015. PMID: 25796566 Review. - Nutrient regulation of mTORC1 at a glance.
Condon KJ, Sabatini DM. Condon KJ, et al. J Cell Sci. 2019 Nov 13;132(21):jcs222570. doi: 10.1242/jcs.222570. J Cell Sci. 2019. PMID: 31722960 Free PMC article. Review.
Cited by
- Host miRNA and mRNA profiles during in DEF and duck after DHAV-1 infection.
Wang M, Liu Z, Cheng A, Wang M, Wu Y, Yang Q, Tian B, Ou X, Sun D, Zhang S, Zhu D, Jia R, Chen S, Liu M, Zhao XX, Huang J. Wang M, et al. Sci Rep. 2024 Sep 29;14(1):22575. doi: 10.1038/s41598-024-72992-x. Sci Rep. 2024. PMID: 39343789 - Functional gene signature offers a powerful tool for characterizing clinicopathological features and depicting tumor immune microenvironment of colorectal cancer.
Zhu Z, Li J, Fa Z, Xu X, Wang Y, Zhou J, Xu Y. Zhu Z, et al. BMC Cancer. 2024 Sep 28;24(1):1199. doi: 10.1186/s12885-024-12996-y. BMC Cancer. 2024. PMID: 39342165 Free PMC article. - mTOR/miR-142-3p/PRAS40 signaling cascade is critical for tuberous sclerosis complex-associated renal cystogenesis.
Zhao S, Hao S, Zhou J, Chen X, Zhang T, Qi Z, Zhang T, Jalal S, Zhai C, Yin L, Bo Y, Teng H, Wang Y, Gao D, Zhang H, Huang L. Zhao S, et al. Cell Mol Biol Lett. 2024 Sep 27;29(1):125. doi: 10.1186/s11658-024-00638-x. Cell Mol Biol Lett. 2024. PMID: 39333852 Free PMC article. - Potential Action Mechanism of Erianin in Relieving MNNG-triggered Chronic Atrophic Gastritis.
Jiang Q, Fan G, Wu K. Jiang Q, et al. Cell Biochem Biophys. 2024 Sep 19. doi: 10.1007/s12013-024-01536-x. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 39298066 - FYVE1/FREE1 is involved in glutamine-responsive TORC1 activation in plants.
Tanigawa M, Maeda T, Isono E. Tanigawa M, et al. iScience. 2024 Aug 26;27(9):110814. doi: 10.1016/j.isci.2024.110814. eCollection 2024 Sep 20. iScience. 2024. PMID: 39297172 Free PMC article.
References
- Alain T, Morita M, Fonseca BD, Yanagiya A, Siddiqui N, Bhat M, Zammit D, Marcus V, Metrakos P, Voyer LA, et al. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies. Cancer research. 2012;72:6468–6476. - PubMed
- Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. The Journal of nutrition. 2000;130:2413–2419. - PubMed
- Aylett CH, Sauer E, Imseng S, Boehringer D, Hall MN, Ban N, Maier T. Architecture of human mTOR complex 1. Science. 2016;351:48–52. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous